| 摘要 |
FIELD: medicine, organic chemistry. SUBSTANCE: invention relates to combination of combination of inhibitor of 5-HT reuptake and selective antagonist or partial agonist h5-HT1B of the formula (I) used for treatment of diseases mediated by 5-hydroxytryptamine, for example, depression, fear and obsessive-compulsive disosder. EFFECT: enhanced effectiveness of combination, valuable medicinal properties. 16 cl, 1 tbl, 2 dwg, 63 ex
|
